Dimensional Fund Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.8M Buy
1,849,032
+252,395
+16% +$1.61M ﹤0.01% 2215
2025
Q1
$7.76M Buy
1,596,637
+492,579
+45% +$2.39M ﹤0.01% 2357
2024
Q4
$10.6M Buy
1,104,058
+444,790
+67% +$4.25M ﹤0.01% 2284
2024
Q3
$5.5M Buy
659,268
+418,500
+174% +$3.49M ﹤0.01% 2499
2024
Q2
$1.64M Sell
240,768
-141,476
-37% -$965K ﹤0.01% 2807
2024
Q1
$967K Sell
382,244
-275,976
-42% -$698K ﹤0.01% 2929
2023
Q4
$1.58M Sell
658,220
-143,383
-18% -$344K ﹤0.01% 2836
2023
Q3
$2.73M Sell
801,603
-687,982
-46% -$2.34M ﹤0.01% 2690
2023
Q2
$10.9M Sell
1,489,585
-321,344
-18% -$2.36M ﹤0.01% 2220
2023
Q1
$18.8M Sell
1,810,929
-28,232
-2% -$292K 0.01% 1936
2022
Q4
$21.7K Sell
1,839,161
-83,069
-4% -$981 0.01% 1835
2022
Q3
$40.3M Sell
1,922,230
-25,102
-1% -$527K 0.02% 1398
2022
Q2
$60.4M Buy
1,947,332
+578,671
+42% +$18M 0.02% 1135
2022
Q1
$56.2M Buy
1,368,661
+342,964
+33% +$14.1M 0.02% 1320
2021
Q4
$44.6M Buy
1,025,697
+39,137
+4% +$1.7M 0.01% 1492
2021
Q3
$49.4M Buy
986,560
+10,722
+1% +$537K 0.02% 1419
2021
Q2
$61.5M Sell
975,838
-73,207
-7% -$4.61M 0.02% 1265
2021
Q1
$97.5M Buy
1,049,045
+12,231
+1% +$1.14M 0.03% 851
2020
Q4
$92.9M Sell
1,036,814
-134,520
-11% -$12.1M 0.03% 800
2020
Q3
$121M Sell
1,171,334
-77,378
-6% -$8M 0.05% 442
2020
Q2
$98.7M Sell
1,248,712
-17,078
-1% -$1.35M 0.04% 569
2020
Q1
$73.2M Sell
1,265,790
-45,710
-3% -$2.64M 0.04% 654
2019
Q4
$70.8M Sell
1,311,500
-187,249
-12% -$10.1M 0.03% 1077
2019
Q3
$78.4M Sell
1,498,749
-139,750
-9% -$7.31M 0.03% 914
2019
Q2
$79.2M Buy
1,638,499
+45,709
+3% +$2.21M 0.03% 924
2019
Q1
$80.5M Sell
1,592,790
-96,950
-6% -$4.9M 0.03% 874
2018
Q4
$100M Sell
1,689,740
-58,081
-3% -$3.44M 0.05% 548
2018
Q3
$115M Sell
1,747,821
-288,463
-14% -$19M 0.04% 586
2018
Q2
$103M Sell
2,036,284
-169,280
-8% -$8.55M 0.04% 637
2018
Q1
$116M Sell
2,205,564
-40,986
-2% -$2.16M 0.05% 511
2017
Q4
$104M Buy
2,246,550
+22,352
+1% +$1.04M 0.04% 588
2017
Q3
$90M Buy
2,224,198
+18,486
+0.8% +$748K 0.04% 666
2017
Q2
$74.8M Buy
2,205,712
+152,029
+7% +$5.16M 0.03% 770
2017
Q1
$59.6M Buy
2,053,683
+28,365
+1% +$824K 0.03% 978
2016
Q4
$66.5M Sell
2,025,318
-20,932
-1% -$687K 0.03% 816
2016
Q3
$64.5M Sell
2,046,250
-103,565
-5% -$3.27M 0.03% 769
2016
Q2
$60.5M Buy
2,149,815
+88,071
+4% +$2.48M 0.03% 770
2016
Q1
$74.9M Buy
2,061,744
+150,099
+8% +$5.46M 0.04% 555
2015
Q4
$76.5M Buy
1,911,645
+112,452
+6% +$4.5M 0.05% 506
2015
Q3
$51.3M Buy
1,799,193
+88,543
+5% +$2.52M 0.03% 776
2015
Q2
$56.4M Buy
1,710,650
+114,788
+7% +$3.78M 0.03% 747
2015
Q1
$45.9M Buy
1,595,862
+94,703
+6% +$2.72M 0.03% 917
2014
Q4
$40.9M Buy
1,501,159
+17,742
+1% +$483K 0.03% 965
2014
Q3
$31.6M Buy
1,483,417
+7,344
+0.5% +$157K 0.02% 1107
2014
Q2
$33.2M Buy
1,476,073
+197,633
+15% +$4.44M 0.02% 1090
2014
Q1
$32.3M Buy
1,278,440
+94,047
+8% +$2.38M 0.02% 1040
2013
Q4
$27.2M Buy
1,184,393
+99,847
+9% +$2.3M 0.02% 1187
2013
Q3
$20.7M Buy
1,084,546
+33,490
+3% +$638K 0.02% 1384
2013
Q2
$15.2M Buy
+1,051,056
New +$15.2M 0.01% 1609